(2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 26 USDMF, 7 EU WC, 2 KDMF, 15 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

101 Drugs in Development

101 Drugs in Development

INTERMEDIATES

40 Intermediate Suppliers

40 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers, 15 FDA Orange Book, 28 Europe, 5 Canada, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG, TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures, 1 Ingredion Pharma Solutions, 16 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 24 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 16 Direct Compression, 15 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 12 Lubricants & Glidants, 10 Topical, 7 Film Formers & Plasticizers, 7 Co-Processed Excipients, 5 Empty Capsules, 5 Coloring Agents, 5 Solubilizers, 5 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 2 Parenteral, 2 Emulsifying Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 141 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 8 Regulatory FDF Prices, 61 Annual Reports

MARKET PLACE

19 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

144 US Patents, 20 US Exclusivities, 44 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 13 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 205879 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
canagliflozin(UNII: 0SAC974Z85) (canagliflozin anhydrous - UNII:6S49DGR869)	canagliflozin anhydrous	150mg \| 150mg \| 50mg \| 50mg
metformin hydrochloride(UNII: 786Z46389E) (metformin - UNII:9100L32L2N)	metformin hydrochloride	1000mg \| 500mg \| 500mg \| 1000mg

Inactive Ingredients

Ingredient Name	Janssen Pharmaceuticals, Inc.
anhydrous lactose(3SY5LH9PMK)
croscarmellose sodium(M28OL1HH48)
ferric oxide red(1K09F3G675)
ferric oxide yellow(EX438O2MRT)
ferrosoferric oxide(XM0M87F357)
HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
hypromellose, unspecified(3NXW29V3WO)
magnesium stearate(70097M6I30)
microcrystalline cellulose(OP1R32D61U)
polyethylene glycol, unspecified(3WJQ0SDW1A)
polyvinyl alcohol, unspecified(532B59J990)
talc(7SEV7J4R1U)
titanium dioxide(15FIX9V2JP)

Setid 9da7283e 9168 45df 9749 Dc51cfcca450 Applno 205879 Form Tablet Extended Release Oral Dosage 150mg 1gm - Drug Product Composition: (2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL